36
Participants
Start Date
March 10, 2017
Primary Completion Date
April 30, 2026
Study Completion Date
December 31, 2026
Lenalidomide
Experimental Arm
Dexamethasone
Experimental Arm
No further treatment
Comparator Arm
Royal United Hospital, Bath
Blackpool Victoria Hospital, Blackpool
University Hospital Wales, Cardiff
Velindre Cancer Centre, Cardiff
Beatson West of Scotland Cancer Centre, Glasgow
St James University Hospital, Leeds
University College London Hospital, London
The Christie Hospital, Manchester
Freeman Hospital, Newcastle
Mount Vernon Cancer Centre, Northwood
Royal Preston Hospital, Preston
Salisbury District Hospital, Salisbury
Southampton General Hospital, Southampton
Collaborators (2)
Cancer Research UK
OTHER
Celgene
INDUSTRY
University College, London
OTHER